On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...